# Biological Age Predicts 90-Day Mortality in Advanced Cancer

> **NCT07035470** · — · COMPLETED · sponsor: **Ankara Etlik City Hospital** · enrollment: 1615 (actual)

## Conditions studied

- Advanced Solid Tumors Cancer
- Hospitalizations

## Interventions

- **OTHER:** PhenoAge-Based Biological Age Assessment

## Key facts

- **NCT ID:** NCT07035470
- **Lead sponsor:** Ankara Etlik City Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-11-05
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 1615 (ACTUAL)
- **Last updated:** 2025-06-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07035470

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07035470, "Biological Age Predicts 90-Day Mortality in Advanced Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07035470. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*